Literature DB >> 28952214

Short- and long-term outcomes of laparoscopic radical hysterectomy for obese patients with cervical cancer.

Huajiang Lei1, Dingqing Gui, Yuhua He.   

Abstract

PURPOSE: To perform a preliminary comparison of the short- and long-term outcomes of laparoscopic hysterectomy (LH) between obese and non-obese patients with cervical cancer.
METHODS: A total of 243 cases of cervical cancer patients were treated with LH between April 2009 and January 2016. Based on their body mass index (BMI) at the time of surgery, patients were divided into an obese group (BMI ≥ 25 kg/m2) and a non-obese group (BMI < 25 kg/m2). The short- and long-term outcomes of the two groups were retrospectively analyzed.
RESULTS: Sixty-four patients were classified as obese and 179 as non-obese. There were no statistically significant differences in age, clinical stage, pathological type, pathological grade, and American Society of Anesthesiologists (ASA) score between the two groups. The proportion of patients with type-2 diabetes mellitus (p=0.006), hypertension (p=0.021), and hyperlipidemia (p=0.008) in the obese group was significantly higher than that in the non-obese group. Compared with the non-obese group, the obese patients had longer operative time (p=0.039), more intraoperative blood loss (p=0.025), and a higher rate of conversion (p=0.025). There was no significant difference between the two groups in terms of intraoperative and postoperative 30-day complications. Pathology data of the two groups were similar. Both groups had similar tumor recurrence rates, 5-year overall survival rates, and 5-year disease-free survival rates.

Entities:  

Mesh:

Year:  2017        PMID: 28952214

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  1 in total

1.  Rising Mortality Rate of Cervical Cancer in Younger Women in Urban China.

Authors:  Min Wei; Wei Zhou; Yongyi Bi; Hong Wang; Yu Liu; Zhi-Jiang Zhang
Journal:  J Gen Intern Med       Date:  2018-11-27       Impact factor: 5.128

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.